Want Better Skin? Using This 1 Thing Before Bed Can Help And It’s Already In Your Home
HuffPost’s “Am I Doing It Wrong” chatted with Dr. Sherwin Parikh to get the lowdown on a nighttime skincare routine that will get you glowing.
HuffPost’s “Am I Doing It Wrong” chatted with Dr. Sherwin Parikh to get the lowdown on a nighttime skincare routine that will get you glowing.
The probe into vaccines and Covid drugs planned for the summer of 2024 has been delayed, inquiry officials have said.
Company faces lawsuit over lead-tainted applesauce – CBS News Watch CBS News Wanabana, one of the companies that has recalled applesauce pouches due to lead contamination, is facing a possible class action lawsuit over the tainted products. Meg Oliver reports. Be the first to know Get browser notifications for breaking news, live events, and exclusive…
CVS Health plans to close select pharmacies inside Target stores early this year, a company spokesperson said Thursday, as retail pharmacy chains in the U.S. struggle to boost profits. The closures will begin in February and finish by the end of April, the spokesperson said in a statement. She added that employees affected by the…
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. “We’ve seen a lot of innovation,” Dan Lyons, portfolio manager on the health-care team at Janus Henderson, said, explaining that he is bullish on 2024 because…
Business & FinanceHealth 15 September 2023, 1:53 pm 1 minute Reuters exclusively reported that Bayer’s (BAYGn.DE) new CEO plans to cut management jobs to speed up decision-making as a first step to overhaul the embattled German industrial group, which is facing investor pressure to break up. Market Impact Anderson has been tasked with reviving Bayer’s…
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their sleeves for an updated version of the jab. The revenue from the shots met Moderna’s forecast for the year, even as sales plummeted from the…